Heterogeneity can predict induction failure in pediatric ALL patients

04/11/2012 | PhysiciansBriefing.com

Children with acute lymphoblastic leukemia who are at risk of induction failure tend to have certain high-risk features, a German study found. Risk factors for induction failure are older age, high leukocyte count, 11q23 rearrangement, T-cell phenotype and Philadephia chromosome, the researchers report in the New England Journal of Medicine. Allogeneic stem-cell transplantation from matched, related donors improved survival in patients with T-cell leukemia, while chemotherapy alone improved survival in children younger than 6 years with precursor B-cell leukemia and no adverse genetic features, the researchers found.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI